CareLit · DOI-Nachweis · Klinische Neurophysiologie
Pregabalin and gabapentin treatment in MS patients: Clinical experiences and therapeutic implications
DOI 10.1055/s-0031-1272712
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS. Bittner, K.G. Höhn, K. Göbel, H. Wiendl, S.G. Meuth
ZeitschriftKlinische Neurophysiologie
Ausgabe03/2011
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Multiple Sclerosis (MS) is a chronic, progressive autoimmune disease of the CNS with a heterogenic clinical presentation. Patients suffer from a variety of symptoms leading to disability and a loss of life's quality. Besides a basic immunomodulatory therapy, many patients receive additional treatment which specifically addresses symptoms such as bladder dysfunction, daytime sleepiness, spasticity or sensory impairme…
Zitieren
Zitierempfehlung
S. Bittner, K.G. Höhn, K. Göbel, H. Wiendl, S.G. Meuth (2011) Pregabalin and gabapentin treatment in MS patients: Clinical experiences and therapeutic implications. Klinische Neurophysiologie (03). https://doi.org/10.1055/s-0031-1272712
Mit CareLit weiterarbeiten